• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重大标准化创伤后的纤维蛋白溶解抑制

Fibrinolysis inhibition after a major standardized trauma.

作者信息

Bagge L, Carlin G, Hjelmstedt A, Högstorp H, Jacobsson H, Modig J, Saldeen T

出版信息

Ups J Med Sci. 1982;87(1):55-66. doi: 10.3109/03009738209178409.

DOI:10.3109/03009738209178409
PMID:6181600
Abstract

The present investigation on 20 patients after total hip replacement surgery has confirmed that the posttraumatic increase of the fibrinolysis inhibition activity (FIA) in serum and plasminogen-depleted serum is due to the primary fibrinolysis inhibitor (PFI, alpha 2-antiplasmin). This protein exists in at least two forms and it was indicated that PFI alpha with affinity to immobilized plasminogen, is mainly responsible for the posttraumatic variations of the FIA in plasminogen-depleted serum. PFI beta, the major part of the PFI-related antigen, which has none or low such affinity, displayed weak FIA and relatively small increase after the surgical trauma. It was established that the posttraumatic increase of the FIA was not derived from the low molecular weight fraction in serum of those patients.

摘要

目前对20例全髋关节置换术后患者的研究证实,血清和纤溶酶原缺乏血清中创伤后纤溶抑制活性(FIA)的增加是由于原发性纤溶抑制剂(PFI,α2 - 抗纤溶酶)所致。该蛋白至少以两种形式存在,并且表明与固定化纤溶酶原有亲和力的PFIα主要负责纤溶酶原缺乏血清中FIA的创伤后变化。PFIβ是PFI相关抗原的主要部分,其没有或只有低亲和力,表现出较弱的FIA,并且在手术创伤后增加相对较小。已确定FIA的创伤后增加并非源自这些患者血清中的低分子量部分。

相似文献

1
Fibrinolysis inhibition after a major standardized trauma.重大标准化创伤后的纤维蛋白溶解抑制
Ups J Med Sci. 1982;87(1):55-66. doi: 10.3109/03009738209178409.
2
Inhibitors of coagulation-fibrinolysis system and platelet function in patients with vertigo.眩晕患者凝血-纤溶系统及血小板功能抑制剂
Auris Nasus Larynx. 1986;13 Suppl 1:S75-9. doi: 10.1016/s0385-8146(86)80038-4.
3
Fibrinolytic and protease inhibitory systems in spinal cord injured patients with end-stage renal disease.终末期肾病脊髓损伤患者的纤溶和蛋白酶抑制系统
J Am Paraplegia Soc. 1993 Jul;16(3):149-52. doi: 10.1080/01952307.1993.11735892.
4
Plasminogen abnormalities in patients with Argentine hemorrhagic fever.阿根廷出血热患者的纤溶酶原异常
Thromb Res. 1987 Dec 15;48(6):713-20. doi: 10.1016/0049-3848(87)90436-1.
5
Inhibitors of fibrinolysis in saliva after oral surgery measured by enzymic and immunological methods.采用酶学和免疫学方法测定口腔手术后唾液中的纤维蛋白溶解抑制剂。
Int J Oral Surg. 1979 Jun;8(3):212-21. doi: 10.1016/s0300-9785(79)80021-6.
6
The study of local fibrinolysis in abortion.流产中局部纤溶作用的研究。
Nihon Sanka Fujinka Gakkai Zasshi. 1985 Jul;37(7):1215-23.
7
Severity of coronary artery disease and basal fibrinolysis.冠状动脉疾病的严重程度与基础纤溶作用
Haemostasis. 1987;17(5):305-11. doi: 10.1159/000215760.
8
[Effect of endogenous fibrinolysis activation on human plasminogen].内源性纤溶激活对人纤溶酶原的影响
Biull Eksp Biol Med. 1987 Jan;103(1):59-61.
9
Depressed fibrinolysis in patients with acute leukaemia.急性白血病患者纤维蛋白溶解功能降低。
Br J Haematol. 1987 Jul;66(3):327-30. doi: 10.1111/j.1365-2141.1987.tb06918.x.
10
Early local and systemic fibrinolytic response to high energy missile trauma.
Acta Chir Scand Suppl. 1982;508:327-36.